Efficacy and Safety of TMZ Plus 6-MP in the Patients With Recurrent Glioblastoma
Clinical trial NCT06279767 · UNKNOWN
Trial details
- NCT number
- NCT06279767
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2025-07-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.